Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:09–249.

Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE. In vitro model systems to study androgen receptor signaling in prostate cancer. Endocr Relat Cancer. 2013;20:R49–64.

Article  CAS  PubMed  Google Scholar 

Wu X, Gong S, Roy-Burman P, Lee P, Culig Z. Current mouse and cell models in prostate cancer research. Endocr Relat Cancer. 2013;20:R155–70. https://doi.org/10.1530/ERC-1512-0285.

Article  CAS  PubMed  Google Scholar 

Cunningham D, You Z. In vitro and in vivo model systems used in prostate cancer research. J Biol methods. 2015;2:e17.

Article  PubMed  Google Scholar 

Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, et al. The LNCaP cell line–a new model for studies on human prostatic carcinoma. Prog Clin Biol Res. 1980;37:115–32.

CAS  PubMed  Google Scholar 

Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol. 1979;17:16–23.

CAS  Google Scholar 

Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer. 1978;21:274–81.

Article  CAS  PubMed  Google Scholar 

Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines. Prostate. 1996;29:386–94.

Article  CAS  PubMed  Google Scholar 

Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. Vitr Cell Developmental Biol Anim. 1995;31:14–24.

Article  CAS  Google Scholar 

Sobel RE, Sadar MD. Cell lines used in prostate cancer research: A compendium of old and new cell lines - Part 2. J Urol. 2005;173:360–72.

Article  CAS  PubMed  Google Scholar 

Sobel RE, Sadar MD. Cell lines used in prostate cancer research: A compendium of old and new cell lines - Part 1. J Urol. 2005;173:342–59.

Article  CAS  PubMed  Google Scholar 

Namekawa T, Ikeda K, Horie-Inoue K, Inoue S. Application of prostate cancer models for preclinical study: Advantages and limitations of cell lines, patient-derived xenografts, and three-dimensional culture of patient-derived cells. Cells. 2019;8:74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frame FM, Noble AR, O’Toole P, Marrison J, Godden T, O’Brien A, et al. Assessing the advantages, limitations and potential of human primary prostate epithelial cells as a pre-clinical model for prostate cancer research. Adv Exp Med Biol. 2019;1164:109–18.

Article  CAS  PubMed  Google Scholar 

Saranyutanon S, Deshmukh SK, Dasgupta S, Pai S, Singh S, Singh AP. Cellular and molecular progression of prostate cancer: Models for basic and preclinical research. Cancers (Basel). 2020;12:2651.

Article  CAS  PubMed  Google Scholar 

Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, et al. hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res. 2006;66:3531–40.

Article  CAS  PubMed  Google Scholar 

Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis. 1996;17:1641–6.

Article  CAS  PubMed  Google Scholar 

Ke X-S, Qu Y, Goldfinger N, Rostad K, Hovland R, Akslen LA, et al. Epithelial to mesenchymal transition of a primary prostate cell line with switches of cell adhesion modules but without malignant transformation. PLOS ONE. 2008;3:e3368.

Article  PubMed  PubMed Central  Google Scholar 

Choo CK, Ling MT, Chan KW, Tsao SW, Zheng Z, Zhang D, et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate. 1999;40:150–8.

Article  CAS  PubMed  Google Scholar 

Lai J, An J, Nelson CC, Lehman ML, Batra J, Clements JA. Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer. Biol Chem. 2014;395:1127–32.

Article  CAS  PubMed  Google Scholar 

Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996–1006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.

Article  PubMed  PubMed Central  Google Scholar 

Liao Y, Smyth GK, Shi W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.

Article  CAS  PubMed  Google Scholar 

Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.

Article  PubMed  PubMed Central  Google Scholar 

Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.

Article  CAS  PubMed  Google Scholar 

Feng J, Meyer CA, Wang Q, Liu JS, Shirley Liu X, Zhang Y. GFOLD: A generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics. 2012;28:2782–8.

Article  CAS  PubMed  Google Scholar 

Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Rios-Colon L, et al. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells. Sci Rep. 2019;9:9776.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Kim C, Liu W, Zhu J, Chin K, Rodriguez-Canales J, et al. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. Int J Cancer. 2020;146:1346–58.

Article  CAS  PubMed  Google Scholar 

Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590–95.

Article  CAS  PubMed  Google Scholar 

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carm KT, Hoff AM, Bakken AC, Axcrona U, Axcrona K, Lothe RA, et al. Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer. Sci Rep. 2019;9:13579.

Article  PubMed  PubMed Central  Google Scholar 

Ceder JA, Aalders TW, Schalken JA. Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations. Stem Cell Res Ther. 2017;8:95.

Article  PubMed  PubMed Central  Google Scholar 

Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis. 1997;18:1215–23.

Article  CAS  PubMed  Google Scholar 

Devlies W, Handle F, Devos G, Joniau S, Claessens F. Preclinical models in prostate cancer: Resistance to AR targeting therapies in prostate cancer. Cancers (Basel). 2021;13:915.

Article  CAS  PubMed  Google Scholar 

Elbadawy M, Abugomaa A, Yamawaki H, Usui T, Sasaki K. Development of prostate cancer organoid culture models in basic medicine and translational research. Cancers (Basel). 2020;12:777.

Article  CAS  PubMed  Google Scholar 

Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J, et al. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. Int J Oncol. 2010;37:1477–82.

CAS  PubMed